Throughout 2021 and into the present, DiResta’s team at the Stanford Internet Observatory (SIO) has been working hard to detect and disrupt mis- and disinformation related to the COVID-19 vaccines in real-time as part of her work leading the Virality Project, a multi-year effort between SIO and five other research groups. (Image credit: Andrew Brodhead)Īs the pandemic continues to be an ongoing health emergency with new variants rapidly spreading, it is increasingly urgent that accurate vaccine-related information be accessible and readily available to the public, said Stanford scholar and leading expert on mis- and disinformation, Renée DiResta. Stanford scholar Renée DiResta is the author of a new report looking how to stop the online spread of mis- and disinformation related to the COVID-19 vaccine. Vaccines are lifesavers.”Ĭontact the UNC Gillings School of Global Public Health communications team at. are 100% effective at preventing death by COVID-19. “All three vaccines available in the U.S. “Friends and family ask me all the time, ‘which vaccine should I get?’ and my answer is always that I would get any vaccine you can whenever you can,” said Sheahan. “It is imperative that government leaders prioritize evidence-driven communication strategies in their COVID-19 vaccine programs,” the Commission writes, “while health care providers maintain situational awareness, respond to public concerns and counter unfounded claims by those seeking to undermine public confidence in vaccines.” It debunks common misconceptions about rushed vaccines, mandatory vaccination and genetic manipulation, as well as other areas of concern linked to conspiracy theories. The article serves as a primer to assist providers in developing cogent and evidence-based answers to misinformation that the public may encounter. He joined the Commission on COVID-19 Vaccines and Therapeutics Task Force in September 2020. He is also part of the team that developed and tested the antiviral drug EIDD-2801, also known as molnupiravir, which is currently being tested in human clinical trials for safety and effectiveness to treat COVID-19. Sheahan, a virologist in the Department of Epidemiology at the UNC Gillings School of Global Public Health, is part of the team that tested the broad-spectrum antiviral drug remdesivir, which gained FDA approval for emergency use treatment of COVID-19 after clinical trials showed that it improved recovery times for infected patients. “This is a life or death situation here, and The Lancet Commission is trying to set the record straight and give health care professionals and the general public the tools to understand vaccine safety and dispel myths that make people hesitant to get vaccinated.” “Vaccination is our best weapon to put the brakes on the COVID-19 pandemic, but there is a lot of conflicting information out there which may give people pause on whether or not to get vaccinated,” Sheahan said. Partisan and anti-vaccine advocates have often exploited these concerns to further spread misinformation. Concerns about efficacy, quality and speed of development have all played a role in public perception of the vaccine, as well as uncertainty among communities that have historically been harmed by scientific misconduct and structural racism in health care. In the United States, hesitancy around the COVID-19 vaccine has been high - even among health care workers - in contrast to the growing acceptance rate of vaccines overall. (Photo by Megan May/UNC-Chapel Hill)Īs part of The Lancet’s Commission on COVID-19 Vaccines and Therapeutics Task Force, Assistant Professor Timothy Sheahan, PhD, has contributed to a new primer for health care providers addressing common misinformation about COVID-19 vaccines.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |